Skip to main content
Year archive

Vivesto — 2013 filings

All 38 regulatory filings released by Vivesto (VIVE) in 2013, sourced directly from the official regulator.

38 Filings
2013 Period
2013 filings (38)
Filing Released Lang
Interim / Quarterly Report 2014
Interim / Quarterly Report H1 2014
2013-12-05 Swedish
Interim / Quarterly Report 2014
Interim / Quarterly Report H1 2014
2013-12-05 English
Major Shareholding Notification 2013
Major Shareholding Notification
2013-12-04 English
FDA godkänner Oasmias produktionsanläggning i Uppsala
Regulatory Filings
2013-12-03 Swedish
Oasmia Announces Successful FDA Pre-Approval Inspection of Its Manufacturing Facility
Regulatory Filings
2013-12-03 English
Nexttobe extends loan to Oasmia
Capital/Financing Update
2013-12-02 English
Nexttobe förlänger sitt lån till Oasmia
Regulatory Filings
2013-12-02 Swedish
Communiqué from Annual General Meeting 2013
AGM Information
2013-10-02 English
Kommuniké från årsstämma 2013
AGM Information
2013-10-02 Swedish
Oasmias två största ägare föreslår Alexander Kotsinas till ny styrelsemedlem
Board/Management Information
2013-09-11 Swedish
Oasmia’s two major shareholders nominate Alexander Kotsinas to new board member
Board/Management Information
2013-09-11 English
Interim / Quarterly Report 2013
Interim / Quarterly Report Q1 2013
2013-09-06 English
Interim / Quarterly Report 2013
Interim / Quarterly Report Q3 2013
2013-09-06 Swedish
Notice of Annual General Meeting
AGM Information
2013-08-28 English
Kallelse till Årsstämma i Oasmia Pharmceutical AB
AGM Information
2013-08-28 Swedish
Annual Report 2013
Annual Report FY 2013
2013-08-22 Swedish
Annual Report 2013
Annual Report FY 2013
2013-08-22 English
Oasmia appoints new Vice President Communications
Board/Management Information
2013-06-13 English
Oasmia anställer ny Vice President Communications
Board/Management Information
2013-06-13 Swedish
Interim / Quarterly Report 2013
Interim / Quarterly Report FY 2013
2013-06-07 Swedish
Interim / Quarterly Report 2013
Interim / Quarterly Report FY 2013
2013-06-07 English
Oasmia’s patented XR-17 technology generates novel cancer combination therapy
Regulatory Filings
2013-05-28 English
Oasmias patenterade teknologi XR-17 möjliggör ny unik kombinationsterapi för behandling av cancer
Legal Proceedings Report
2013-05-28 Swedish
Oasmia initierar kliniskt program för behandling av bröstcancer med Paclical®
Legal Proceedings Report
2013-05-06 Swedish
Oasmia initiates clinical program with Paclical® in metastatic breast cancer
Legal Proceedings Report
2013-05-06 English
Interim / Quarterly Report 2013
Interim / Quarterly Report 9M 2013
2013-03-01 Swedish
Interim / Quarterly Report 2013
Interim / Quarterly Report 9M 2013
2013-03-01 English
Oasmia Pharmaceutical förstärker och breddar ledningsgruppen
Board/Management Information
2013-02-11 Swedish
Oasmia Pharmaceutical strengthens its management team
Board/Management Information
2013-02-11 English
Oasmia Pharmaceutical AB: Oasmia signs marketing and distribution agreement for product candidate Paclical(R) in Russia and CIS countries
Regulatory Filings
2013-02-04 English
Oasmia signs marketing and distribution agreement for product candidate Paclical® in Russia and CIS countries
M&A Activity
2013-02-04 English
Oasmia tecknar distributionsavtal för produktkandidaten Paclical i Ryssland och OSS
Regulatory Filings
2013-02-04 Swedish
Major Shareholding Notification 2013
Major Shareholding Notification
2013-01-15 English
Nexttobe ökar sitt ägande i Oasmia
Major Shareholding Notification
2013-01-15 Swedish
Nexttobe increases their ownership in Oasmia
Major Shareholding Notification
2013-01-15 English
Oasmia Pharmaceutical AB: Oasmia Pharmaceutical AB and Abbott Sign Global Collaboration Agreement for Canine Oncology Therapies
M&A Activity
2013-01-07 English
Oasmia och Abbott tecknar globalt samarbetsavtal för den veterinäronkologiska marknaden
Regulatory Filings
2013-01-07 Swedish
Oasmia Pharmaceutical AB and Abbott Sign Global Collaboration Agreement for Canine Oncology Therapies
Regulatory Filings
2013-01-07 English